Watch Demo

Sweden Healthcare Industry Outlook 2022 - 2026

See how Sweden Healthcare performed compared to key markets such as the United States, Switzerland and Norway.

Key Market Indicators

Swedish Health Expenditure is set to reach $7,370 PPP Per Capita by 2026 from $6,560 PPP Per Capita in 2021, growing 1.9% year on year on average. Since 2005, Swedish demand grew 3.5% year on year. The country ranked number 6 in 2021, Austria overtook with $6,560 PPP Per Capita. Switzerland, Norway and Germany respectively were numbers 2, 3 and 4 in this ranking.

Sweden Healthcare Market Data and Forecasts

Purchase Reports from Reputable Market Research Publishers

Sweden Buy Now Pay Later Business and Investment Opportunities – 75+ KPIs on Buy Now Pay Later Trends by End-Use Sectors, Operational KPIs, Market Share, Retail Product Dynamics, and Consumer Demographics - Q1 2022 Update
Sweden Buy Now Pay Later Business and Investment Opportunities – 75+ KPIs on Buy Now Pay Later Trends by End-Use Sectors, Operational KPIs, Market Share, Retail Product Dynamics, and Consumer Demographics - Q1 2022 Update
  • $ 2400
  • January 2022
  • 50 pages
Medical Simulation Market Size, Share & Trends Analysis Report By Product & Services, By Technology, By End Use And Segment Forecasts, 2021 - 2028
Medical Simulation Market Size, Share & Trends Analysis Report By Product & Services, By Technology, By End Use And Segment Forecasts, 2021 - 2028
  • $ 5950
  • November 2021
  • 150 pages
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update New
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
  • $ 2000
  • November 2022
  • 77 pages
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
  • $ 2000
  • April 2022
  • 160 pages
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Drugs in Development, 2021
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Drugs in Development, 2021
  • $ 2000
  • November 2021
  • 115 pages
Myocarditis (Cardiovascular) - Drugs In Development, 2021
Myocarditis (Cardiovascular) - Drugs In Development, 2021
  • $ 2000
  • June 2021
  • 57 pages
Myocarditis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Myocarditis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
  • $ 2000
  • March 2022
  • 45 pages
Idiopathic Thrombocytopenic Purpura (Hematology) - Drugs In Development, 2021
Idiopathic Thrombocytopenic Purpura (Hematology) - Drugs In Development, 2021
  • $ 2000
  • July 2021
  • 205 pages
Portable Minimally Invasive Surgery Simulators Market
Portable Minimally Invasive Surgery Simulators Market
  • $ 4900
  • May 2022
  • 295 pages
Sweden Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape New
Sweden Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape
  • $ 1995
  • November 2022
  • 161 pages